Facephi Biometria Statistics

Total Valuation

BME:FACE has a market cap or net worth of EUR 56.90 million. The enterprise value is 72.43 million.

Market Cap	56.90M
Enterprise Value	72.43M

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	n/a

Share Statistics

BME:FACE has 24.11 million shares outstanding. The number of shares has increased by 25.43% in one year.

Current Share Class	n/a
Shares Outstanding	24.11M
Shares Change (YoY)	+25.43%
Shares Change (QoQ)	-8.09%
Owned by Insiders (%)	10.27%
Owned by Institutions (%)	17.87%
Float	21.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.68
PB Ratio	3.26
P/TBV Ratio	13.56
P/FCF Ratio	40.03
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-12.27
EV / Sales	2.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	50.95

Financial Position

The company has a current ratio of 0.69, with a Debt / Equity ratio of 1.01.

Current Ratio	0.69
Quick Ratio	0.69
Debt / Equity	1.01
Debt / EBITDA	n/a
Debt / FCF	11.49
Interest Coverage	-3.43

Financial Efficiency

Return on equity (ROE) is -41.21% and return on invested capital (ROIC) is -14.70%.

Return on Equity (ROE)	-41.21%
Return on Assets (ROA)	-10.90%
Return on Invested Capital (ROIC)	-14.70%
Return on Capital Employed (ROCE)	-39.67%
Revenue Per Employee	135,343
Profits Per Employee	-25,332
Employee Count	264
Asset Turnover	0.75
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.69% in the last 52 weeks. The beta is 1.30, so BME:FACE's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	+20.69%
50-Day Moving Average	2.24
200-Day Moving Average	1.79
Relative Strength Index (RSI)	56.50
Average Volume (20 Days)	29,183

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BME:FACE had revenue of EUR 31.53 million and -5.90 million in losses. Loss per share was -0.26.

Revenue	31.53M
Gross Profit	27.85M
Operating Income	-7.33M
Pretax Income	-8.62M
Net Income	-5.90M
EBITDA	-6.56M
EBIT	-7.33M
Loss Per Share	-0.26

Full Income Statement

Balance Sheet

The company has 817,342 in cash and 16.34 million in debt, giving a net cash position of -15.52 million or -0.64 per share.

Cash & Cash Equivalents	817,342
Total Debt	16.34M
Net Cash	-15.52M
Net Cash Per Share	-0.64
Equity (Book Value)	16.22M
Book Value Per Share	0.72
Working Capital	-8.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.90 million and capital expenditures -482,389, giving a free cash flow of 1.42 million.

Operating Cash Flow	1.90M
Capital Expenditures	-482,389
Free Cash Flow	1.42M
FCF Per Share	0.06

Full Cash Flow Statement

Margins

Gross margin is 88.33%, with operating and profit margins of -23.23% and -18.72%.

Gross Margin	88.33%
Operating Margin	-23.23%
Pretax Margin	-27.33%
Profit Margin	-18.72%
EBITDA Margin	-20.82%
EBIT Margin	-23.23%
FCF Margin	4.51%

Dividends & Yields

BME:FACE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.43%
Shareholder Yield	-25.43%
Earnings Yield	-10.37%
FCF Yield	2.50%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BME:FACE has an Altman Z-Score of 0.64. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.64
Piotroski F-Score	n/a